Immune Dysfunction and Immunotherapy in Heart DiseaseISBN: 978-1-4051-5568-7
Hardcover
328 pages
September 2007, Wiley-Blackwell
|
Current heart failure therapeutics affects symptoms without
appreciably reducing the mortality rate of 50% in five years --
suggesting a failure in treating the underlying mechanism. This
book proposes a new mechanism for heart failure; immune mediated
cardiac remodelling for cardiac dysfunction.
The outstanding editor team of two internationally recognized
immunologists -- Ronald Watson, who has studied heart disease in
immune dysfunction for a decade and has a patent for an
immunotherapy of heart disease by immune regulation, and Douglas
Larson, whose experience in cardiac transplantation immunology has
provided the foundation for research into novel therapeutics for
heart failure and hypertension – makes Immune Dysfunction and
Immunotherapy in Heart Disease the definitive reference to the
state of the science in this area.
The four parts of the book address:
- Immune Dysfunction Leading to Heart Disease: Induction by
Physiological Changes
- Immune Dysfunction Promoting CVD: Induction by Transplantation
Drugs
- Immune Dysfunction Leading to Heart Dysfunction: Induction or
Prevention by Cardiotherapeutic Drugs
- Immune Dysfunction Leading to Heart Disease: Induction by Pathogens
Both researchers and practitioners will find this authoritative volume an excellent source of information on novel immune targeted therapeutics.